FdaApplication

ANDA 090538

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGLENMARK PHARMACEUTICALS LTD
application_typeANDA
approval_date2011-03-22

Products (1)

ProductActive ingredientStrengthDosage form
BRIELLYNETHINYL ESTRADIOL; NORETHINDRONE0.035MG;0.4MGTABLET;ORAL-28

1 product